FDA fast tracks one-time intravitreal gene therapy for geographic atrophy
By: Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: SAR446597 is designed to inhibit C1s and factor Bb in the complement pathway. Fast-track designation expedites the development and…